AKT signalling is required for ribosomal RNA synthesis and progression of Eμ-Myc B-cell lymphoma in vivo
Version of Record online: 13 FEB 2013
© 2013 The Authors Journal compilation © 2013 FEBS
The FEBS Journal
Special Issue: Frontiers in Cell Signalling, and Ca2+-Signalling and Transport in Health and Disease
Volume 280, Issue 21, pages 5307–5316, November 2013
How to Cite
Devlin, J. R., Hannan, K. M., Ng, P. Y., Bywater, M. J., Shortt, J., Cullinane, C., McArthur, G. A., Johnstone, R. W., Hannan, R. D. and Pearson, R. B. (2013), AKT signalling is required for ribosomal RNA synthesis and progression of Eμ-Myc B-cell lymphoma in vivo. The FEBS Journal, 280: 5307–5316. doi: 10.1111/febs.12135
- Issue online: 15 OCT 2013
- Version of Record online: 13 FEB 2013
- Accepted manuscript online: 19 JAN 2013 08:05AM EST
- Manuscript Revised: 14 JAN 2013
- Manuscript Accepted: 14 JAN 2013
- Manuscript Received: 29 NOV 2012
- National Health and Medical Research Council of Australia. Grant Numbers: 1043884, 251608, 566702, 166908, 251688, 509087, 400116, 400120, 566876
- Cancer Council of Victoria
- Leukaemia Foundation of Australia
Fig. S1. The maximum tolerated dose of MK-2206 is 200 mg/kg.
Fig. S2. MK-2206 induces apoptotic cell death in spleen and axillary lymph nodes.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.